Close Menu

NEW YORK – While PCR-, antigen-, and antibody-based technologies have been the backbone technologies in the development of SARS-CoV-2 diagnostics tests, other methods not usually used in the life sciences are also being explored as strategies to improve the detection of the coronavirus.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.